Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
BeiGene
BeiGene
Children's Oncology Group
Hutchmed
Ipsen
Jiangsu HengRui Medicine Co., Ltd.
Medical College of Wisconsin
Pfizer
Azienda Ospedaliero, Universitaria Pisana
Jiangsu HengRui Medicine Co., Ltd.
Takeda
University of Miami
Millennium Pharmaceuticals, Inc.
National Heart, Lung, and Blood Institute (NHLBI)
AstraZeneca
Fred Hutchinson Cancer Center